Literature DB >> 6350003

The renin-angiotensin--aldosterone system and the clinical course of acute myocardial infarction.

B Michorowski, L Ceremuzyński.   

Abstract

To determine whether the renin--angiotensin--aldosterone system is stimulated in myocardial infarction, plasma renin activity and serum aldosterone were measured by radioimmunoassay in 95 patients with acute infarction. Urinary catecholamines, and sodium and potassium levels in blood and urine were also determined. Plasma renin activity and aldosterone were insignificantly increased in mild myocardial infarction as compared to a reference group comprising patients with angina pectoris. In patients with a complicated course, however, they were greatly augmented. A close correlation was found between urine catecholamines and plasma renin activity and between urine noradrenaline and aldosterone. Aldosterone values were highly correlated with the urine potassium/sodium ratio.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350003     DOI: 10.1093/oxfordjournals.eurheartj.a061457

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

Review 1.  The renin-angiotensin system and coronary vasomotion.

Authors:  G Ertl; K Hu; W R Bauer; B Bauer
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 2.  Neuroendocrine activation after myocardial infarction: causes and consequences.

Authors:  J G Cleland; P J Cowburn; K Morgan
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 3.  Perindopril. A review of its pharmacokinetics and clinical pharmacology.

Authors:  R J Macfadyen; K R Lees; J L Reid
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 4.  Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?

Authors:  A Sigurdsson; K Swedberg
Journal:  Br Heart J       Date:  1994-09

5.  Coronary vessel diameters during and after primary percutaneous coronary artery intervention.

Authors:  M Sahin; S Demir; G Kocabay; M Bulut; G Alici; B Ozkan; A Fedakar; M Turkmen; B Boztosun
Journal:  Herz       Date:  2013-07-07       Impact factor: 1.443

6.  Mitral Leaflet Changes Following Myocardial Infarction: Clinical Evidence for Maladaptive Valvular Remodeling.

Authors:  Jonathan Beaudoin; Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; J Luis Guerrero; Suzanne Sullivan; Philipp Emanuel Bartko; Mark D Handschumacher; Dae-Hee Kim; Jill Wylie-Sears; Jacob Aaron; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2017-11       Impact factor: 7.792

Review 7.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

8.  Neuroendocrine activation after acute myocardial infarction.

Authors:  H M McAlpine; J J Morton; B Leckie; A Rumley; G Gillen; H J Dargie
Journal:  Br Heart J       Date:  1988-08

9.  Calcium channel blocker prevents stress-induced activation of renin and aldosterone in conscious pig.

Authors:  L Ceremuzyński; J Kloś; B Barcikowski; K Herbaczyńska-Cedro
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

10.  Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial.

Authors:  A Pipilis; M Flather; R Collins; A Hargreaves; T Kolettis; N Boon; C Foster; P Appleby; P Sleight
Journal:  Br Heart J       Date:  1993-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.